New Zealand markets closed

Vertex Pharmaceuticals Incorporated (VRTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
393.10-1.07 (-0.27%)
At close: 04:00PM EDT
393.52 +0.42 (+0.11%)
Pre-market: 05:55AM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
9,869,200
9,869,200
8,930,700
7,574,400
6,205,700
Cost of revenue
1,262,200
1,262,200
1,080,300
904,200
736,300
Gross profit
8,607,000
8,607,000
7,850,400
6,670,200
5,469,400
Operating expenses
Research development
3,162,900
3,162,900
2,540,300
1,937,800
1,829,500
Selling general and administrative
1,136,600
1,136,600
944,700
840,100
770,500
Total operating expenses
4,299,500
4,299,500
3,485,000
2,777,900
2,600,000
Operating income or loss
4,307,500
4,307,500
4,365,400
3,892,300
2,869,400
Interest expense
44,100
44,100
54,800
61,500
58,200
Total other income/expenses net
-498,300
-498,300
-222,800
-1,105,300
283,500
Income before tax
4,379,800
4,379,800
4,232,400
2,730,400
3,116,900
Income tax expense
760,200
760,200
910,400
388,300
405,200
Income from continuing operations
3,619,600
3,619,600
3,322,000
2,342,100
2,711,700
Net income
3,619,600
3,619,600
3,322,000
2,342,100
2,711,700
Net income available to common shareholders
3,619,600
3,619,600
3,322,000
2,342,100
2,711,700
Basic EPS
13.48
14.05
12.97
9.09
10.44
Diluted EPS
13.32
13.89
12.82
9.01
10.29
Basic average shares
257,525
257,700
256,100
257,700
259,841
Diluted average shares
260,375
260,500
259,100
259,900
263,396